Expression of Chemokines in GVHD Target Organs Is Influenced by Conditioning and Genetic Factors and Amplified by GVHR

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 6, 2006, Pages 623-634

  Mapara, Markus Y ^a,b   Leng, Corinna ^c   Kim, Yong Mi ^a   Bronson, Roderick ^d   Lokshin, Anna ^b   Luster, Andrew ^a   Sykes, Megan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d TUFTS UNIVERSITY   (United States)

Author keywords

Bone marrow transplantation; Chemokine; CXCR3; Graft versus host disease; Knockout mouse

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; COBALT 60; CYCLOPHOSPHAMIDE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCLONAL ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG SENSITIVITY; FEMALE; GRAFT VERSUS HOST REACTION; HEREDITY; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE; ISOGRAFT; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MOUSE; MOUSE STRAIN; MYELOABLATIVE CONDITIONING; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPLEEN CELL; STRAIN DIFFERENCE; T LYMPHOCYTE; TARGET ORGAN; TH1 CELL; TISSUE LEVEL; UPREGULATION;

ANIMALS; CHEMOKINES; CHEMOKINES, CXC; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; KINETICS; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, CHEMOKINE; RIBONUCLEASES; SKIN; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 33646820021     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.02.005     Document Type: Article

References (41)

1. Weiden P.L., Flournoy N., Thomas E.D., et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med 300 (1979) 1068-1073
2. Weiden P.L., Sullivan K.M., Flournoy N., Storb R., and Thomas E.D. Antileukemic effect of chronic graft-versus-host disease. N Engl J Med 304 (1981) 1529-1533
3. Horowitz M.M., Gale R.P., Sondel P.M., et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75 (1990) 555-562
4. Fontaine P., Roy-Proulx G., Knafo L., Baron C., Roy D.C., and Perreault C. Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease. Nat Med 7 (2001) 789-794
5. Mapara M.Y., Kim Y.-M., Wang S.P., Bronson R., Sachs D.H., and Sykes M. Donor lymphocyte infusions (DLI) mediate superior graft-versus-leukemia (GvL) effects in mixed compared to fully allogeneic chimeras. a critical role for host antigen-presenting cells. Blood 100 (2002) 1903-1909
6. Shlomchik W.D., Couzens M.S., Tang C.B., et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285 (1999) 412-415
7. Sykes M., Sheard M.A., and Sachs D.H. Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells. J Exp Med 168 (1988) 2391-2396
8. Hill G.R., Teshima T., Gerbitz A., et al. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia. J Clin Invest 104 (1999) 459-467
9. Cooke K.R., Hill G.R., Gerbitz A., et al. Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation 70 (2000) 272-279
10. Hill G.R., and Ferrara J.L. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease. rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 95 (2000) 2754-2759
11. Hill G.R., Teshima T., Rebel V.I., et al. The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity. J Immunol 164 (2000) 656-663
12. Holler E., Kolb H.J., Moller A., et al. Increased serum levels of tumor necrosis factor precede major complications of bone marrow transplantation. Blood 75 (1990) 1011-1016
13. Ferrara J.L.M., Levy R., and Chao N.J. Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol Blood Marrow Transplant 5 (1999) 347-356
14. Mapara M., Kim Y.-M., Marx J.E., and Sykes M. DLI-mediated GVL effects in mixed chimeras established with a nonmyeloablative conditioning regimen. extinction of GVL effects following conversion to full donor chimerism. Transplantation 76 (2006) 297-305
15. Nelson P.J., and Krensky A.M. Chemokines, chemokine receptors, and allograft rejection. Immunity 14 (2001) 377-386
16. Medoff B.D., Sauty A., Tager A.M., et al. IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J Immunol 168 (2002) 5278-5286
17. Khan I.A., MacLean J.A., Lee F.S., et al. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12 (2000) 483-494
18. Gonzalo J.A., Lloyd C.M., Wen D., et al. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 188 (1998) 157-167
19. Lloyd C.M., Minto A.W., Dorf M.E., et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 185 (1997) 1371-1380
20. Hancock W.W., Gao W., Csizmadia V., Faia K.L., Shemmeri N., and Luster A.D. Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 193 (2001) 975-980
21. Panoskaltsis-Mortari A., Strieter R.M., Hermanson J.R., et al. Induction of monocyte- and T-cell-attracting chemokines in the lung during the generation of idiopathic pneumonia syndrome following allogeneic murine bone marrow transplantation. Blood 96 (2000) 834-839
22. Nikolic B., Lee S., Bronson R.T., Grusby M.J., and Sykes M. Th1 and Th2 cells both contribute to acute GVHD, and each subset has distinct end-organ targets. J Clin Invest 105 (2000) 1289-1293
23. Hancock W.W., Lu B., Gao W., et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 192 (2000) 1515-1520
24. Mapara M.Y., Pelot M., Zhao G., Swenson K., Pearson D., and Sykes M. Induction of stable long-term mixed hematopoietic chimerism following a cyclophosphamide-based non-myeloablative conditioning regimen leads to donor-specific in vitro and in vivo tolerance. Biol Blood Marrow Transplant 7 (2001) 646-655
25. Kim Y.M., Sachs T., Asavaroengchai W., Bronson R., and Sykes M. Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720. J Clin Invest 111 (2003) 659-669
26. Luckow B., Maier H., Chilla S., and Perez de Lema G. The mCK-5 multiprobe RNase protection assay kit can yield erroneous results for the murine chemokines IP-10 and MCP-1. Anal Biochem 286 (2000) 193-197
27. Oliver K.G., Kettman J.R., and Fulton R.J. Multiplexed analysis of human cytokines by use of the FlowMetrix system. Clin Chem 44 (1998) 2057-2060
28. de Jager W., te Velthuis H., Prakken B.J., Kuis W., and Rijkers G.T. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 10 (2003) 133-139
29. Pelot M.R., Pearson D.A., Swenson K., et al. Lymphohematopoietic graft-vs-host reactions can be induced without graft-vs-host disease in murine mixed chimeras established with a cyclophosphamide-based non-myeloablative conditioning regimen. Biol Blood Marrow Transplant 5 (1999) 133-143
30. Kolb H.-J., Schattenberg A., Goldman J.M., et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86 (1995) 2041-2050
31. Panoskaltsis-Mortari A., Hermanson J.R., Taras E., Wangensteen O.D., Serody J.S., and Blazar B.R. Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1 alpha (CCL3) after allogeneic BMT in mice. Blood 101 (2003) 3714-3721
32. Serody J.S., Burkett S.E., Panoskaltsis-Mortari A., et al. T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease. Blood 96 (2000) 2973-2980
33. Serody J.S., Cook D.N., Kirby S.L., Reap E., Shea T.C., and Frelinger J.A. Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier. Blood 93 (1999) 43-50
34. Murai M., Yoneyama H., Harada A., et al. Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest 104 (1999) 49-57
35. Scheerens H., Hessel E., de Waal-Malefyt R., Leach M.W., and Rennick D. Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease. IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+CD45RBhigh T cells. Eur J Immunol 31 (2001) 1465-1474
36. Beilhack A., Schulz S., Baker J., et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 106 (2005) 1113-1122
37. Wysocki C.A., Burkett S.B., Panoskaltsis-Mortari A., et al. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. J Immunol 173 (2004) 845-854
38. Dufour J.H., Dziejman M., Liu M.T., Leung J.H., Lane T.E., and Luster A.D. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168 (2002) 3195-3204
39. Duffner U., Lu B., Hildebrandt G.C., et al. Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol 31 (2003) 897-902
40. Fra A.M., Locati M., Otero K., et al. Cutting edge. scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J Immunol 170 (2003) 2279-2282
41. Mantovani A., Locati M., Vecchi A., Sozzani S., and Allavena P. Decoy receptors. a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol 22 (2001) 328-336